Advocates fear new federal legislation will make it harder to open safe injection sites in future Canada’s first supervised injection site has received a Health Canada exemption that allows it to continue to operate, days after passage of federal legislation that critics fear will make it harder to open new facilities. Vancouver Coastal Health is […]
Insite supervised injection site receives Health Canada exemption Read More »
Liberal Party leader Justin Trudeau has reaffirmed his support for an expansion of supervised injection services across Canada. At the same event, the would-be prime minister also restated his belief that hard drugs should not be decriminalized. Trudeau was speaking in Vancouver at the University of British Columbia on March 4. A few members of
Justin Trudeau tells UBC students he wants supervised injection sites across Canada Read More »
It’s been a year since the application went to Health Canada for a second supervised injection site in Vancouver…so what’s happening? The Conservative Government’s delayed approval of a second supervised injection site in Vancouver has left a lingering question – is the site going to disappear? Vancouver Mayor Gregor Robertson is just one of many
Vancouver Mayor: “InSite is crucial to this city” Read More »
The Canadian Coalition of Organizations Responding to Hepatitis B and C has issued a report card on Canada’s performance and found that resources are inconsistent across the country. Co-ordination appears particularly poor in Prince Edward Island, Nunavut and the Northwest Territories and prison inmates across the country are especially vulnerable, the group says in its
Safe injection sites needed Canada-wide to fight hep B, C Read More »
UN recommends made-in-BC strategy to reshape global AIDS response Secretary-General’s report calls for linkage of treatment and prevention Treatment as Prevention, the groundbreaking HIV treatment paradigm pioneered at the BC Centre for Excellence in HIV/AIDS (BC-CfE), has been endorsed by a recently released United Nations report. The report identifies Treatment as Prevention as a key
New cases of HIV among those who use drugs by injection continue to decline in B.C., according to a report by the provincial health officer. A major factor in the decline has been the expansion of Highly Active Anti-retroviral Therapy (HAART) and harm reduction programs, says the report. Introduced in 1997, HAART is a combination
New HIV cases drop among injection drug users in BC Read More »
A new report says there are fewer new cases of HIV among injection drug users in B.C., and health officials are crediting the province’s harm reduction programs. The report by the provincial health officer says the number of new HIV infections has remained stable nationally, but in B.C. in 2009 there were 64 new cases
Health officials credit harm reduction for decline in B.C. HIV cases Read More »
B.C.’s top doctor is pushing to keep harm reduction and anti-retroviral therapy as key health strategies after a new report showed rates of HIV infection among those who inject drugs continues to drop. Provincial health officer Dr. Perry Kendall released the report noting several reasons why intravenous drug users aren’t catching HIV or hepatitis C
HIV dropping among IV drug users due to harm reduction, says B.C.’s health officer Read More »
Harm reduction measures and anti-retroviral therapy are cutting down B.C.’s HIV infection rates among injection drug users, says a new report released Thursday by the Health Ministry. Provincial health officer Dr. Perry Kendall released a report revealing several factors associated with the drop in intravenous drug users catching HIV or hepatitis C. Among the factors
HIV rates among injection drug users continue to drop Read More »
China chooses made-in-BC approach to combat HIV and AIDS worldwide World’s most populous nation embraces treatment as prevention The BC Centre for Excellence in HIV/AIDS (BC-CfE) hosted a Chinese delegation led by Dr. Zunyou Wu last year to share their expertise on the internationally recognized treatment as prevention strategy and collaborate on the development of
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
